Searched for
WOCKHARDT EBITDA GROWTH
Wockhardt shares jump 17%, hit fresh 52-week highWockhardt extended its winning streak for the third straight session, drawing strong investor interest with trading volumes surging over 4....11 Jun, 2025, 03.25 PM IST- Wockhardt Q2 Results: Net loss narrows to Rs 16 crore, revenue rises 7%Drugmaker Wockhardt on Wednesday reported a net loss of Rs 16 crore in Q2FY25 led by improved performance across UK, India and emerging mar...13 Nov, 2024, 08.41 PM IST
- Wockhardt Q1 Results: Net loss narrows to Rs 16 croreThe Mumbai-based drug maker reported a net loss of Rs 136 crore in Q1FY25. Revenue rose 14% year-on-year (y-o-y) to Rs.747 crore in Q1FY25 ...09 Aug, 2024, 07.50 PM IST
- Wockhardt reports net loss of Rs 237 crore in Q4FY23Wockhardt had agreed to pay $36 million and interest over nine installments between 2022 and 2025 to the State of Texas in a drug pricing c...26 May, 2023, 09.32 PM IST
- Dr Reddy’s Q2 numbers in line with estimatesDr Reddy’s has come out with a decent set of numbers on revenue, EBITDA and profitability fronts, says Nikhil Shetty.28 Oct, 2020, 03.10 PM IST
- Brokerages raise Dr Reddy’s EPS estimate, but upside looks cappedAnalysts expect the acquisition to be funded through a bridge loan, with quick de-leveraging by FY22 through internal accruals.14 Feb, 2020, 09.01 AM IST
- Cipla, PAG eye Wockhardt’s formulations businessWockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other coun...28 Jan, 2020, 08.47 AM IST
- Wockhardt has focused on consolidation in Q1: Habil Khorakiwala“We expect to introduce two new drugs in Indian market next year.”07 Aug, 2018, 10.29 AM IST
- Look at Lupin, Sun Pharma or Torrent Pharma: Avinnash GorakssakarIn a chat with ET Now, Avinnash Gorakssakar, Precision Investment, says the two-wheeler market will underperform for a couple of quarters04 Feb, 2016, 03.53 PM IST
- Brokers' Call: Wockhardt, SBI and ApolloBofA-ML is optimistic on Wockhardt's growth prospects, led by a differentiated US pipeline, as well as an improving growth trajectory in it...28 May, 2013, 05.22 AM IST
- Analysts bullish on Wockhardt due to its proven growth potentialPreviously a bankruptcy case, the firm has emerged stronger and is trading at a discount to its peers.10 Dec, 2012, 08.16 AM IST
- Macquarie maintains 'outperform' rating on WockhardtMacquarie has maintained a 'Outperform' rating on Wockhardt with an increased target price of Rs 1,575. Wockhardt expects total sales to gr...23 Aug, 2012, 04.16 PM IST
- Wockhardt clears the debt mess, posts 95% YoY growth in Q1The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.06 Aug, 2012, 08.27 PM IST
- Wockhardt: Will investors forgive the company?Forget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.03 Mar, 2011, 01.40 PM IST
- Investors unwilling to forgive Wockhardt, promoter for failingsForget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.03 Mar, 2011, 06.40 AM IST
- Wockhardt sells nutritionals biz to AbbottWockhardt has sold its nutritionals business comprising top-selling brands Farex, Protinex, Dexolac and Nusobee, and manufacturing units at...29 Jul, 2009, 01.12 AM IST
- Wockhardt buys out Irish co for Rs 690 crMumbai-based pharmaceutical firm Wockhardt on Tuesday said the company has acquired Pinewood Laboratories, one of the largest and fastest g...04 Oct, 2006, 01.10 AM IST
Load More
